Omnix Biopharmaceuticals (OMRI-Q) Stock Predictions - Stockchase
WATCH LIST
2
Omnix Biopharmaceuticals (OMRI-Q)

ON STOCKCHASE SINCE Nov 2006

biotechnology/pharmaceutical

Omnix Biopharmaceuticals

OMRI-Q

0 watching          
Join the Discussion

Omnix Biopharmaceuticals (OMRI-Q) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about OMRI-Q



  • All
  • Filtered
Signal Opinion Expert
PAST TOP PICK
(A Top Pick Nov 20/06. Up 30%.) Missed a quarter and there were competitive threats so he got out and missed the upswing.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Nov 20/06. Up 30%.) Missed a quarter and there were competitive threats so he got out and missed the upswing.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$37.820
Owned Owned
No

TOP PICK
Using plasma to stop bleeding in the surgical applications. 200% growth. Sells at about 20 X earnings. Management owns a big chunk. Just reported stellar numbers. Will ultimately get taken over.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Using plasma to stop bleeding in the surgical applications. 200% growth. Sells at about 20 X earnings. Management owns a big chunk. Just reported stellar numbers. Will ultimately get taken over.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$29.840
Owned Owned
Yes

Showing 1 to 2 of 2 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days